Abstract
After separating the *F and *S alleles by electrophoresis the allele-specific hemolytic activity was detected by agarose overlay method using the programmable densitometer for scanning. The hemolytic activity of BF allotypes was analyzed from 81 individuals. In thirteen FS heterozygous serum samples BF F had lower hemolysis than BF S. Four FF homozygous samples also exhibited lower hemolysis than a homozygous control sample. The low hemolytic activity of F in FS heterozygotes was not due to decreased protein concentrations relative to S. On the contrary, BF F was associated with higher protein concentration than BF S. The relative quantitation of the allele specific BF protein was done by crossed immunoelectrophoresis. BF F with low hemolytic activity but with high protein concentration associated strongly with HLA B35 phenotype and the family material confirmed the association with the haplotypes A3, Cw4, B35, DR1, BFFB, C4A3BQO (or A2BQO, A3,2BQO). The results suggest that particular MHC haplotypes contain a factor B allele with encoding for poor hemolytic activity or that MHC haplotype specific regulatory elements affect pre- or post-translational activity levels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alper, C. A., Boenisch, T., and Watson, L.: Genetic polymorphism in human glycine-rich-beta-glycoprotein. J Exp Med 135: 68–80, 1972
Amos, D., Badir, H., Boyle, W., McQueen, M., and Tiilikainen, A.: A simple micro-cytotoxicity test. Transplantation 7: 220–223, 1969
Awdeh, Z. L. and Alper, C. A.: Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci USA 77: 3576–3580, 1980
Campbell, R. D., Dunham, I., Kendall, E., and Sargent, C. A.: Polymorphism of the human complement component CC4. Exp Clin Immunogenet 7: 69–84, 1990
Carroll, M. C., Campbell, R. D., Bentley, D. R., and Porter, R. R.: A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature 307: 237–241, 1984
Falus, A., Kramer, J., Walcz, E., Varga, Z., Setalo, J., Jobst, K., Lakatos, T., and Meretey, K.: Unequal expression of complement C4A and C4B genes in rheumatoid synovial cells, human monocytoid and hepatoma-derived cell lines. Immunology 68: 133–136, 1989
Ganrot, P.-O.: Crossed immunelectrophoresis. Scand J Clin Lab Invest 29, suppl 124: 39–47, 1972
Geserick, G. and Patzelt, D.: Factor B (BF) subtyping by isoelectric focusing: Methods, nomenclatures, genetics and forensic application. Electrophoresis 9: 418–421, 1988
Hauptmann, G. M., Tongio, M. M., and Mayer, S.: BF polymorphism: study of a new variant (FO.55). Hum Genet 33: 275–278, 1976
Horiuchi, T., Macon, K. J., Kidd, V. J., and Volanakis, J. E.: Translational regulation of complement protein C2 expression by differential utilization of the 5′-untranslated region of mRNA. J Biol Chem 265: 6521–6524, 1990
Lokki, M.-L. and Koskimies, S.: Two BF*F subtypes found by isoelectric focusing have restricted distributions in the Finnish MHC haplotypes. Complement Inflamm 7: 102–108, 1990
Mancini, G., Carbonara, A., and Heremans, J.: Immunochemistryquantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235–254, 1965
Mauff, G., Adam, R., Wachauf, B., Hitzeroth, H. W., and Hiller, Chr.: Serum concentration and functional efficiency of factor B alleles. Immunobiology 158: 86–90, 1980
Mauff, G., Alper, C. A., and Awdeh, Z.:Statement on the nomenclature of human C4 allotypes. Immunobiology 164: 184–191, 1983
McLean, R. H., Donohue, P. A., Jospe, N., Bias, W. B., VanDop, C., and Migeon, C.: Restriction fragment analysis of duplication of the fourth component of complement (C4A). Genomics 2: 76–85, 1988
Mortensen, J. P. and Lamm, L. U.: Quantitative differences between complement factor-B phenotypes. Immunology 12: 505–511, 1981
Nonaka, M., Ishikawa, N., Passwell, J.,Natsuume-Sakai, S., and Colten, H. R.: Tissue-specific initiation of murine complement factor B mRNA transcription. J Immunol 142: 1377–1382, 1989
Sheehy, M. J., Scharf, S. J., Rowe, J. R., Neme de Gimenez, M. H., Mashe, L. M., Erlich, H. A., and Nepom, B. S.: A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and DQ alleles. J Clin Invest 83: 830–835, 1989
Sim, E. and Cross, S. J.: Phenotyping of human complement component C4, a class-III HLA antigen. Biochem J 239: 763–767, 1986
Spies, T., Bresnahan, M., and Strominger, J. L.: Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B. Proc Natl Acad Sci USA 86: 8955–8958, 1989
Teng, Y. S. and Tan, S. G.: Subtyping of properdin factor B (Bf) by isoelectrofocusing. Hum Hered 32: 362–366, 1982
Todd, J. A., Acha-Orbea, H., Bell, J. I., Chao, N., Fronek, Z., Jacob, C. O., McDermott, M., Sinha, A. A., Timmerman, L., Steinman, L., and McDevitt, H. O.: Molecular basis for MHC class II-associated autoimmunity. Science 240: 1003–1009, 1988
Truedsson, L., Awdeh, Z., Yunis, E. J.,Mrose, S., Moore, B., and Alper, C. A., Quantitative variation of C4 variant proteins associated with many MHC haplotypes. Immunogenetics 30: 414–421, 1989
Weidinger, S., Schwarzfischer, F., and Cleve, H.: Properdin factor B polymorphism. An indication for the existence of a Bf°-allele. Z Rechtsmed 83: 259–264, 1979
Wu, L.-C., Morley, B. J., and Campbell, R. D.: Cell-specific expression of the human complement protein factor B gene: Evidence for the role of two distinct 5′-flanking elements. Cell 48: 331–342, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lokki, ML., Koskimies, S.A. Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes. Immunogenetics 34, 242–246 (1991). https://doi.org/10.1007/BF00215259
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00215259